Washington University School of Medicine in St. Louis has developed a saliva-based test for COVID-19 that is faster and easier than the swab tests currently in use. The test could help simplify and expand the availability of COVID-19 diagnostic testing across broad populations.
A study led by researchers at Washington University School of Medicine details the nature of delays in autism diagnoses for African American children. Such delays can result in significant consequences for young children and their families.
Washington University School of Medicine scientists have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible to the novel coronavirus.
COVID-19 caught public health systems in the U.S. unprepared to detect, track and contain the virus. The pandemic has exposed a multitude of deficiencies that require a wholesale reinvention of the field of public health, said four leading experts in a recently published essay.
Gastric bypass surgery is the most effective therapy to treat or reverse type 2 diabetes in severely obese patients. New research from Washington University School of Medicine indicates that weight loss after surgery, rather than the surgery itself, drives metabolic improvements.
Across 30 major U.S. cities, an average of 63% of public schools are located within 1,000 feet — about two city blocks — of a store selling tobacco and e-cigarette products, according to a comprehensive new study mapping tobacco retailers.
School of Medicine researchers have received a $3.9 million grant supporting new technologies and therapeutics to advance a drug to treat debilitating lung diseases, including asthma and chronic obstructive pulmonary disease. The research is led by Michael J. Holtzman, MD.
In a mouse study, researchers at Washington University School of Medicine in St. Louis have found that an antibody that targets the protein TREM2 empowers tumor-destroying immune cells and improves the effectiveness of cancer immunotherapy.
School of Medicine researchers are investigating whether a drug approved by the Food and Drug Administration to treat rare diseases of an overactive immune system could help critically ill patients hospitalized with COVID-19.
Researchers at Washington University School of Medicine in St. Louis have created a COVID-19 vaccine candidate from a replicating virus. This experimental vaccine has proven effective at preventing pneumonia in mice.